IN8bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IN8bio generated cash of -$23,340,000, which is more than the previous year. Cash used in financing activities reached the amount of $27,044,000 last year. Net change in cash is therefore $2,848,000.
Cash Flow
| 2018 | -2.76M | -757K | 8.50M |
|---|---|---|---|
| 2019 | -4.80M | 356K | 65K |
| 2020 | -7.13M | 0 | 24.51M |
| 2021 | -13.50M | -309K | 32.95M |
| 2022 | -24.12M | -3.70M | 8.98M |
| 2023 | -23.34M | -600K | 27.04M |
INAB Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 18.43M | 37.27M | 18.13M | 610K | 4.99M | 15K |
Operating activities | ||||||
Net income | -30.00M | -28.52M | -14.65M | -8.55M | -5.13M | -2.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.50M | 1.10M | 788K | 88K | 96K | 96K |
Stock-based compensation expense | 4.37M | 3.46M | 2.19M | 357K | 76K | 0 |
| Deferred income tax benefit | 4.37M | 3.46M | 2.19M | 357K | 76K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 30K | 0 |
Inventories | 0 | 0 | 0 | 0 | -30K | 0 |
Accounts payable | -981K | 1.51M | -319K | -160K | 141K | -152K |
Cash generated by operating activities | -23.34M | -24.12M | -13.50M | -7.13M | -4.80M | -2.76M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -600K | -3.70M | -309K | 0 | -330K | -757K |
Acquisitions Net | 0 | 0 | 0 | 0 | 686K | 0 |
Cash generated by investing activities | -600K | -3.70M | -309K | 0 | 356K | -757K |
Financing activities | ||||||
Common Stock Issued | 24.56M | 9.54M | 36.32M | 499K | 65K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -798K | -615K | -709K | -174K | 0 | -803K |
Cash used in financing activities | 27.04M | 8.98M | 32.95M | 24.51M | 65K | 8.50M |
Net Change In Cash | 2.84M | -18.83M | 19.13M | 17.38M | -4.38M | 4.97M |
Cash at end of period | 21.28M | 18.43M | 37.27M | 17.99M | 610K | 4.99M |
| Data source | Data source | Data source |